USG Celebrates its Longstanding Partnership With the DRC to Improve Access to Life-Saving Medicines and Health Commodities

Kinshasa, November 18, 2017 – The United States Embassy Kinshasa is pleased to announce the closeout of three projects funded by the U.S. Government through the U.S. Agency for International Development (USAID): the DELIVER project, Systems for Improved Access to Pharmaceuticals and Services (SIAPS) and Supply Chain Management System (SCMS).

For more than three years, these three projects have worked to strengthen the governance of the Democratic Republic of the Congo (DRC) pharmaceutical sector, developed normative documents and strategic plans, and revised the curriculum of the Faculty of Pharmaceutical Sciences of the University of Kinshasa. USAID’s support also allowed the integration of the National Drug Supply System, with capacity building support to the Federation of Medicines Supply and Distribution Centers (Fedecame) and National Programs of the Ministry of Health.

Furthermore, USAID has supported the health sector by providing quality medicines and making available to the Congolese population nearly 31 million diagnostic tests for malaria and 31 million doses of treatment. In addition, there are four million HIV testing and a significant amount of antiretroviral (ARV) treatments sufficient to maintain treatment among 33,000 people living with HIV over a 3 year period. The United States Government has invested a total of $90 million solely in quality commodities procurement for HIV and malaria. Between 2011 and 2016, US Government funding to the Health sector in the DRC is estimated at $800 million.

The closeout of these projects today does not mark the end of USG support as they will be replaced by another USAID funded Project Global Health Supply Chain (GHSC) for the next five years with an estimated budget of $200 million. The Government of the United States will continue to support the Congolese Government in achieving the Sustainable Development Goals by 2030.